ArticleThe journal of headache and pain2009
CADASIL presenting as status migrainosus and persisting aura without infarction.
Article in The journal of headache and pain, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 15 citations in OpenAlex.
- The First Report of CADASIL in Peru: Olfactory Dysfunction on Initial Presentation.eNeurologicalSci · 2016Article
- Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.The journal of headache and pain · 2012Article
- Grey matter volume alterations in CADASIL: a voxel-based morphometry study.The journal of headache and pain · 2012Article
- Rapid improvement of a complex migrainous episode with sodium valproate in a patient with CADASIL.The journal of headache and pain · 2012Review
- Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?The journal of headache and pain · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Different types of migraine have been reported in 20-40% of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We describe a novel migrainous manifestation of CADASIL consisting in status migrainosus and persistent aura without infarction. The symptoms resolved after i.v. treatment with lorazepam and mannitol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.